The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2
about
The epsin family of endocytic adaptors promotes fibrosarcoma migration and invasionRole of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.Dab2 links CIN85 with clathrin-mediated receptor internalizationIdentification of novel VHL target genes and relationship to hypoxic response pathwaysAIP1 mediates TNF-alpha-induced ASK1 activation by facilitating dissociation of ASK1 from its inhibitor 14-3-3DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosisAIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in miceAIP1 functions as Arf6-GAP to negatively regulate TLR4 signalingDAB2IP in cancerDab2IP GTPase activating protein regulates dendrite development and synapse number in cerebellumDisabled-2 is required for efficient hemostasis and platelet activation by thrombin in miceThe adaptor protein Disabled-2: new insights into platelet biology and integrin signalingCell cycle-dependent phosphorylation of Disabled-2 by cdc2Signaling pathways of ESE-16, an antimitotic and anticarbonic anhydrase estradiol analog, in breast cancer cellsDab2ip regulates neuronal migration and neurite outgrowth in the developing neocortexCharacterization of a novel negative regulator (DOC-2/DAB2) of c-Src in normal prostatic epithelium and cancerEpithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.Negative regulation of DAB2IP by Akt and SCFFbw7 pathwaysLoss of disabled-2 expression is an early event in esophageal squamous tumorigenesis.A common genetic variant (97906C>A) of DAB2IP/AIP1 is associated with an increased risk and early onset of lung cancer in Chinese males.Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines.The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.Novel diagnostic biomarkers for prostate cancer.Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer.Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancerNegative regulation of the endocytic adaptor disabled-2 (Dab2) in mitosis.Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer.A systems genetics study of swine illustrates mechanisms underlying human phenotypic traitsLoss of Dab2 expression in breast cancer cells impairs their ability to deplete TGF-β and induce Tregs development via TGF-β.Transcriptomics of maternal and fetal membranes can discriminate between gestational-age matched preterm neonates with and without cognitive impairment diagnosed at 18-24 months.DOC-2/DAB2 interacting protein status in high-risk prostate cancer correlates with outcome for patients treated with radiation therapy.Expression of mouse Dab2ip transcript variants and gene methylation during brain development.Epigenetic silencing of a Ca(2+)-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers.A Novel Monoclonal Antibody Against Human DAB2IP.The positive feedback between Snail and DAB2IP regulates EMT, invasion and metastasis in colorectal cancer.Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.The mechanism of DAB2IP in chemoresistance of prostate cancer cells.Pretreatment biopsy analysis of DAB2IP identifies subpopulation of high-risk prostate cancer patients with worse survival following radiation therapySmurf1 regulation of DAB2IP controls cell proliferation and migration
P2860
Q24295295-A86A5B60-3440-4A8E-BEDD-1FB0A42499E9Q24295609-9291D254-2735-471A-A117-9018711F29DEQ24299168-E3014C24-DD8B-40B0-8E54-35E77D8D66A5Q24299968-17FBBB21-DB40-4A2B-B343-1773F868D222Q24305453-7D7BD6D7-25B9-4CB3-AE51-D9CF6B289D66Q24316141-2DDDBC35-1BBD-493F-8506-655F6AA41380Q24318212-98EF8842-B943-4C89-957A-2785160D57D6Q24323383-20327FD0-F857-470B-B477-8200D4725BC4Q26776456-4A4DA39D-6975-44DC-B671-232D4D81D461Q27321121-6EB7C391-6E1C-4D08-B088-9A3A98DFF546Q27342751-7CB515A1-8594-4A01-B6A1-517CD47F3A02Q28074277-29F6E9E4-0012-4334-8736-3B60B7929AB4Q28189608-90272A30-4999-47F4-88CD-8CA2229C376CQ28485895-F1284B86-E76F-4FD8-BD3B-047A92C7528BQ28505693-7AD2EE5D-DB65-431C-88D4-6AF53514031BQ28581678-EF1C9418-CC49-433D-A97B-8A5B6236FCF4Q33351622-930E33A8-37FA-4D57-A869-A59D1B908ECEQ33594982-0DEF27F9-DF05-4E1E-AFD1-4E4993201304Q33917635-51636D31-C842-4A54-8746-DA14D1D1F585Q34013092-7516C25C-5967-4890-BC27-4457B582FB60Q34064865-59152C5D-646A-41D4-85BD-C0E081B86F5BQ34160419-E1479640-22BC-4F36-A92E-A8A08217D41FQ34227747-B7CE5B11-82A7-4666-B3A0-EFFCDCD89032Q34231678-208FF98B-E55E-4B55-A408-9E31AE3645A8Q34409667-451A06B0-B638-4AB5-A341-F0FF66DC6E67Q34540268-8BBFAF94-F389-48AB-94A5-3A694AE87D1DQ34568457-224B336A-8A6C-42AA-B9EE-4B6CD4E6C6B8Q35051774-1646D1BF-E461-4DFD-8D91-4862EA60DE61Q35108511-05A9C57D-F9D5-4BF5-B2B5-0E2F02B6069DQ35123215-28C5ED88-8471-4CC8-A420-022D1866CF6BQ35231766-BC27DB58-7AFB-443E-AABA-3DDD630B97FFQ35729485-9F49DF0C-9695-4251-9D20-2BFB177077B1Q35759432-4BACF62E-1CD4-4972-8D05-C2609D7DA2CEQ35927921-BCFB7F56-E00F-42F5-91D1-630D861E270EQ36011799-83029966-A227-4849-832F-4827B84EA620Q36413800-2182D9D0-F84A-4F56-A459-B3AF8F377F86Q36688972-E7B295CD-2E30-4434-836D-853DD3AEECCEQ36725756-5E728F6A-5226-4F7A-915E-C01F98CD5165Q37084855-C95D89C1-1B0C-4B4D-9E65-CF485263C432Q37295581-B52D2E63-D9C7-4E41-8737-942689349B71
P2860
The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
The mechanism of growth-inhibi ...... -terminal domain of DOC-2/DAB2
@ast
The mechanism of growth-inhibi ...... -terminal domain of DOC-2/DAB2
@en
The mechanism of growth-inhibi ...... -terminal domain of DOC-2/DAB2
@en-gb
The mechanism of growth-inhibi ...... -terminal domain of DOC-2/DAB2
@nl
type
label
The mechanism of growth-inhibi ...... -terminal domain of DOC-2/DAB2
@ast
The mechanism of growth-inhibi ...... -terminal domain of DOC-2/DAB2
@en
The mechanism of growth-inhibi ...... -terminal domain of DOC-2/DAB2
@en-gb
The mechanism of growth-inhibi ...... -terminal domain of DOC-2/DAB2
@nl
prefLabel
The mechanism of growth-inhibi ...... -terminal domain of DOC-2/DAB2
@ast
The mechanism of growth-inhibi ...... -terminal domain of DOC-2/DAB2
@en
The mechanism of growth-inhibi ...... -terminal domain of DOC-2/DAB2
@en-gb
The mechanism of growth-inhibi ...... -terminal domain of DOC-2/DAB2
@nl
P2093
P2860
P3181
P356
P1476
The mechanism of growth-inhibi ...... -terminal domain of DOC-2/DAB2
@en
P2093
Ching-Ping Tseng
Jer-Tsong Hsieh
John D McConnell
Nora Navone
Rey-Chen Pong
P2860
P304
P3181
P356
10.1074/JBC.M110568200
P407
P577
2002-04-12T00:00:00Z